103632-6
Natalizumab Ab [Mass/volume] in Serum by Immunoassay
Active
Part Descriptions
LP64671-8 Natalizumab
Natalizumab is a humanized monoclonal antibody against the cellular adhesion molecule α4-integrin. Natalizumab is used in the treatment of multiple sclerosis and Crohn's disease. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood-brain barrier. Natalizumab has proven effective in treating the symptoms of both diseases, preventing relapse, vision loss, cognitive decline and significantly improving quality of life in people with multiple sclerosis, as well as increasing rates of remission and preventing relapse in Crohn's disease.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Wikipedia
LP64672-6 Natalizumab Ab
Drug therapy for MS - loses effectiveness when patients develop antibodies to the drug. Detecting the antibodies early allows healthcare providers the opportunity to prescribe alternative therapy and avoid the cost associated with failed therapy.
Source: Regenstrief Institute
LOINC Names Get Info
- Fully-Specified Name
- Natalizumab Ab:
MCnc: Pt: Ser: Qn: IA - Long Common Name
- Natalizumab Ab [Mass/volume] in Serum by Immunoassay
- Short Name
- Natalizumab Ab Ser IA-mCnc
- Display Name
- Natalizumab Ab IA (S) [Mass/Vol]
- Consumer Name Alpha Get Info
- Natalizumab antibody, Blood
Part Model Get Info
Basic Attributes
- Class
- SERO
- Type
- Laboratory
- First Released
- Version 2.79
- Last Updated
- Version 2.79 (ADD)
- Order vs. Observation
- Both
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Ναταλιζουμάμπη Αντίσωμα: Synonyms: IA MCnc Pt Qn SERO Αντίσωμα Ναταλιζουμάμπη Ορός |
| es-ES | Spanish (Spain) | Natilizumab Anticuerpos: Synonyms: Cuantitativo |
| et-EE | Estonian (Estonia) | Natalisumaab antikehad: Synonyms: Juhuslik Kvantitatiivne Seerum |
| fr-FR | French (France) | Natalizumab Ac: |
| fr-BE | French (Belgium) | Natalizumab Ac: Synonyms: Anticorps |
| fr-CA | French (Canada) | Natalizumab, Ac: |
| it-IT | Italian (Italy) | Natalizumab Ab: Synonyms: anticorpo Concentrazione di Massa Immunoassay Punto nel tempo (episodio) Siero Sierologia (anticorpi e la maggior parte degli ant |
| nl-NL | Dutch (Netherlands) | natalizumab As: Synonyms: antistof; |
| pl-PL | Polish (Poland) | Natalizumab Ab: Synonyms: Natalizumab |
| ru-RU | Russian (Russian Federation) | Натализумаб Ат: Synonyms: Антитело Количественный Массовая концентрация Сыворотка Точка во времени; |
| tr-TR | Turkish (Turkey) | Natalizumab Ab: Synonyms: Ak İmmünölçüm, immünoassay |
| zh-CN | Chinese (China) | 那他珠单抗 抗体: Synonyms: Ab; |
Example Units
| Unit | Source |
|---|---|
| ng/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://